Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-04-27 Purchase | 2021-04-29 7:45 pm | IMPEL NEUROPHARMA INC | IMPL | Norwest Venture Partners XIV LP Crowe Jeffrey HAQUE PROMOD Kossow Jon Erik 10% Owner | 825,000 | $15 | $12,375,000 | 3,077,198 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-04-27 Conversion | 2021-04-29 7:45 pm | N/A 2021-12-31 | IMPEL NEUROPHARMA INC | IMPL | Norwest Venture Partners XIV LP Crowe Jeffrey HAQUE PROMOD Kossow Jon Erik 10% Owner | 38,735,370 | $0 | 3,077,198 (Direct) | View |
| 2021-04-27 Conversion | 2021-04-29 7:45 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | Norwest Venture Partners XIV LP Crowe Jeffrey HAQUE PROMOD Kossow Jon Erik 10% Owner | 98,927 | $13.5 | 3,077,198 (Direct) | View |
| 2021-04-22 Other | 2021-04-26 7:02 pm | N/A 2021-12-31 | IMPEL NEUROPHARMA INC | IMPL | Norwest Venture Partners XIV LP Crowe Jeffrey HAQUE PROMOD Kossow Jon Erik 10% Owner | 1,325,893 | $0 | 1,325,893 (Direct) | View |
Ownership | 2021-04-22 7:29 pm | N/A N/A | IMPEL NEUROPHARMA INC | IMPL | Norwest Venture Partners XIV LP Crowe Jeffrey HAQUE PROMOD Kossow Jon Erik 10% Owner | 0 | $0 | 2,153,271 (Direct) | View |